Heartflow (HTFL) Cash & Equivalents (2023 - 2026)

Heartflow has reported Cash & Equivalents for 4 years, with the latest figure at $246.8 million in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 207.69% year-over-year to $246.8 million in Q2 2026; TTM through Jun 2026 was $246.8 million, a 207.69% increase from a year earlier, with the FY2025 full-year figure at $44.8 million, down 19.82% from the prior year.
• Cash & Equivalents was $246.8 million for Q2 2026 at Heartflow, up from $44.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $291.2 million in Q3 2025, with the low at $44.8 million in Q4 2025.
• Average Cash & Equivalents over 4 years is $122.7 million, with a median of $77.8 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents plunged 54.51% in 2024, then jumped 350.35% in 2025.
• Over 4 years, Cash & Equivalents stood at $122.8 million in 2023, then slumped by 54.51% to $55.8 million in 2024, then slipped by 19.82% to $44.8 million in 2025, then surged by 451.19% to $246.8 million in 2026.
• The last three Cash & Equivalents figures came in at $246.8 million (Q2 2026), $44.8 million (Q4 2025), and $291.2 million (Q3 2025), per Business Quant data.